Meloxicam
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Meloxicam(F05809) |
| 2D Structure | |
| FRCD ID | F05809 |
| CAS Number | 71125-38-7 |
| PubChem CID | 54677470 |
| Formula | C14H13N3O4S2 |
| IUPAC Name | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide |
| InChI Key | ZRVUJXDFFKFLMG-UHFFFAOYSA-N |
| InChI | InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19) |
| Canonical SMILES | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O |
| Isomeric SMILES | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O |
| Synonyms |
Mobec
meloxicam
71125-38-7
Mobic
Metacam
Movalis
Mobicox
Meloxicam (Mobic)
Meloxicamum
Movatec
|
| Classifies |
Predicted: Plant Toxin
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Organoheterocyclic compounds |
| Class | Benzothiazines |
| Subclass | Not available |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Benzothiazines |
| Alternative Parents | |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Alpha-amino acid or derivatives - Benzothiazine - N-arylamide - 2,5-disubstituted 1,3-thiazole - Ortho-thiazine - Benzenoid - Organosulfonic acid amide - Azole - Heteroaromatic compound - Vinylogous acid - Thiazole - Organosulfonic acid or derivatives - Organic sulfonic acid or derivatives - Carboxamide group - Secondary carboxylic acid amide - Azacycle - Carboxylic acid derivative - Organic oxygen compound - Organic nitrogen compound - Carbonyl group - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Organonitrogen compound - Organooxygen compound - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as benzothiazines. These are organic compounds containing a benzene fused to a thiazine ring (a six-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 351.395 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Complexity | 628 |
| Monoisotopic Mass | 351.035 |
| Exact Mass | 351.035 |
| XLogP | 3 |
| Formal Charge | 0 |
| Heavy Atom Count | 23 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB- | 0.9811 |
| Human Intestinal Absorption | HIA+ | 0.9156 |
| Caco-2 Permeability | Caco2+ | 0.8484 |
| P-glycoprotein Substrate | Substrate | 0.5181 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7516 |
| Non-inhibitor | 0.7491 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9275 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.4348 |
| Metabolism | ||
| CYP450 2C9 Substrate | Substrate | 0.5637 |
| CYP450 2D6 Substrate | Non-substrate | 0.9117 |
| CYP450 3A4 Substrate | Non-substrate | 0.6649 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9271 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.5511 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9322 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8948 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8191 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7316 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9579 |
| Non-inhibitor | 0.7999 | |
| AMES Toxicity | Non AMES toxic | 0.8576 |
| Carcinogens | Non-carcinogens | 0.7052 |
| Fish Toxicity | High FHMT | 0.8811 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9476 |
| Honey Bee Toxicity | Low HBT | 0.7855 |
| Biodegradation | Not ready biodegradable | 0.9312 |
| Acute Oral Toxicity | II | 0.6971 |
| Carcinogenicity (Three-class) | Non-required | 0.6941 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -3.7597 | LogS |
| Caco-2 Permeability | 1.2073 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 3.4619 | LD50, mol/kg |
| Fish Toxicity | 1.6914 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.5386 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Milk | Japan | 0.01ppm | |||
| Other Terrestrial Mammals,Edible Offal | Japan | 0.07ppm | |||
| Pig,Edible Offal | Japan | 0.06ppm | |||
| Cattle,Edible Offal | Japan | 0.07ppm | |||
| Other Terrestrial Mammals,Kidney | Japan | 0.07ppm | |||
| Pig,Kidney | Japan | 0.09ppm | |||
| Cattle,Kidney | Japan | 0.1ppm | |||
| Other Terrestrial Mammals,Liver | Japan | 0.07ppm | |||
| Pig,Liver | Japan | 0.06ppm | |||
| Cattle,Liver | Japan | 0.07ppm | |||
| Other Terrestrial Mammals,Fat | Japan | 0.02ppm | |||
| Pig,Fat | Japan | 0.1ppm | |||
| Pig,Muscle | Japan | 0.02ppm | |||
| Cattle,Muscle | Japan | 0.02ppm | |||
| Cattle,Fat | Japan | 0.02ppm | |||
| Other Terrestrial Mammals,Muscle | Japan | 0.02ppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| Changes in feeding, social, and lying behaviors in dairy cows with metritisfollowing treatment with a nonsteroidal anti-inflammatory drug as adjunctivetreatment to an antimicrobial. | J Dairy Sci | 2018 May | 29477521 |
| Gastroscopic Study of Meloxicam, Tramadol, and Their Combined Administration onthe Development of Gastric Injuries in Dogs. | Top Companion Anim Med | 2017 Sep | 29291772 |
| Evaluation of in-feed larch sawdust anti-inflammatory effect in sows. | Pol J Vet Sci | 2017 Mar 1 | 28865211 |
| Clinical trial of local anesthetic protocols for acute pain associated withcaustic paste disbudding in dairy calves. | J Dairy Sci | 2017 Aug | 28551190 |
| YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuatesneurodegenerative changes induced by β-amyloid (1-42) or double transgenicoverexpression of APP and PS1 via inhibition of cyclooxygenase-2. | J Neuroinflammation | 2017 Apr 27 | 28449688 |
| Evaluation of meloxicam for the treatment of obstructive feline idiopathiccystitis. | J Feline Med Surg | 2016 Nov | 26672127 |
| Addition of meloxicam to the treatment of clinical mastitis improves subsequentreproductive performance. | J Dairy Sci | 2016 Mar | 26778316 |
| Hot topic: Early postpartum treatment of commercial dairy cows with nonsteroidal antiinflammatory drugs increases whole-lactation milk yield. | J Dairy Sci | 2016 Jan | 26519977 |
| Meloxicam inhibits fipronil-induced apoptosis via modulation of the oxidativestress and inflammatory response in SH-SY5Y cells. | J Appl Toxicol | 2016 Jan | 25772694 |
| Experimental study on the effect of oral meloxicam administration in sows onpre-weaning mortality and growth and immunoglobulin G transfer to piglets. | Prev Vet Med | 2016 Apr 1 | 26874363 |
| Development of Analytical Method and Monitoring of Veterinary Drug Residues inKorean Animal Products. | Korean J Food Sci Anim Resour | 2016 | 27433102 |
| A multiresidue liquid chromatographic/tandem mass spectrometric method for thedetection and quantitation of 15 nonsteroidal anti-inflammatory drugs (NSAIDs) inbovine meat and milk. | Anal Bioanal Chem | 2015 Jun | 25814273 |
| Toxic influence. | Nature | 2014 Oct 23 | 25341753 |
| Comparison of meloxicam and a glucosamine-chondroitin supplement in management offeline osteoarthritis. A double-blind randomised, placebo-controlled, prospectivetrial. | Vet Comp Orthop Traumatol | 2014 | 24146058 |
| Hemodynamic and behavioral differences after administration of meloxicam,buprenorphine, or tramadol as analgesics for telemeter implantation in mice. | J Am Assoc Lab Anim Sci | 2013 Sep | 24041211 |
| Effects of meloxicam on milk production, behavior, and feed intake in dairy cows following assisted calving. | J Dairy Sci | 2013 Jun | 23567050 |
| Pharmacokinetics and milk secretion of gabapentin and meloxicam co-administeredorally in Holstein-Friesian cows. | J Vet Pharmacol Ther | 2013 Feb | 22372845 |
| Aspirin augments IgE-mediated histamine release from human peripheral basophilsvia Syk kinase activation. | Allergol Int | 2013 Dec | 24153330 |
| Target animal safety study of meloxicam administered via transmucosal oral spray (Promist(®) technology) for 6 months in dogs. | J Vet Pharmacol Ther | 2013 Aug | 23009183 |
| Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice. | Comp Med | 2013 Apr | 23582417 |